Search

Your search keyword '"Pharoah, Paul D. P."' showing total 1,602 results

Search Constraints

Start Over You searched for: Author "Pharoah, Paul D. P." Remove constraint Author: "Pharoah, Paul D. P." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,602 results on '"Pharoah, Paul D. P."'

Search Results

1. Understanding the genetic complexity of puberty timing across the allele frequency spectrum

2. Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

3. Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum

4. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

5. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

7. Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

8. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

9. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

10. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

12. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

13. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

14. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

15. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Responsep53 Pathway SNPs and Mutations Interact to Affect Cancer

16. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

17. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

18. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

19. Relevance of the MHC region for breast cancer susceptibility in Asians

20. Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma

21. Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium

22. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus

23. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

24. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

25. Rare germline copy number variants (CNVs) and breast cancer risk

26. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

27. Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

28. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

29. Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

30. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

31. Multi-omic machine learning predictor of breast cancer therapy response

33. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

34. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence

35. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

36. Abstract B047: Development and validation of an improved risk stratification model for ovarian cancer

37. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

38. RE: "RISK PREDICTION FOR EPITHELIAL OVARIAN CANCER IN 11 UNITED STATES-BASED CASE-CONTROL STUDIES: INCORPORATION OF EPIDEMIOLOGIC RISK FACTORS AND 17 CONFIRMED GENETIC LOCI".

39. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry

40. Fine-mapping analysis including over 254 000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

41. Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.

43. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

44. Cancer therapy shapes the fitness landscape of clonal hematopoiesis

45. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation

46. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women

47. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

49. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

50. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts

Catalog

Books, media, physical & digital resources